Skip to main content
Top
Published in: BMC Physiology 1/2015

Open Access 01-12-2015 | Research article

Antenatal maternal low protein diet: ACE-2 in the mouse lung and sexually dimorphic programming of hypertension

Authors: Ravi Goyal, Jonathan Van-Wickle, Dipali Goyal, Lawrence D. Longo

Published in: BMC Physiology | Issue 1/2015

Login to get access

Abstract

Elevated blood pressure is an important global health problem, and in-utero under-nutrition may be an important factor in the pathogenesis of hypertension. In the present study, we tested the hypothesis that antenatal maternal low protein diet (MLPD) leads to sexually dimorphic developmental programming of the components of the pulmonary renin-angiotensin system. This may be important in the antenatal MLPD-associated development of hypertension. In pregnant mice, we administered normal (control) and isocaloric 50 % protein restricted diet, commencing one week before mating and continuing until delivery of the pups. From the 18th to 24th week postnatal, we measured blood pressure in the offspring by use of a non-invasive tail-cuff method. In the same mice, we examined the mRNA and protein expression of the key components of the pulmonary renin-angiotensin system. Also, we examined microRNA complementary to angiotensin converting enzymes (ACE) 2 in the offspring lungs. Our results demonstrate that as a consequence of antenatal MLPD: 1) pup birthweight was significantly reduced in both sexes. 2) female offspring developed hypertension, but males did not. 3) In female offspring, ACE-2 protein expression was significantly reduced without any change in the mRNA levels. 4) miRNA 429, which has a binding site on ACE-2 - 3’ UTR was significantly upregulated in the female antenatal MLPD offspring. 5) In males, ACE-2 mRNA and protein expression were unaltered. We conclude that in the mouse, antenatal MLPD-induced reduction of ACE-2 in the female offspring lung may be an important mechanisms in sexually dimorphic programming of hypertension.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rodríguez-Moran M et al. Family history of hypertension and cardiovascular risk factors in prepubertal children. Am J Hypertens. 2010;23:299–304.CrossRefPubMed Rodríguez-Moran M et al. Family history of hypertension and cardiovascular risk factors in prepubertal children. Am J Hypertens. 2010;23:299–304.CrossRefPubMed
2.
go back to reference Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989;298:564–7.CrossRefPubMedCentralPubMed Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME. Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ. 1989;298:564–7.CrossRefPubMedCentralPubMed
3.
go back to reference Goyal R, Wong C, Van Wickle J, Longo LD. Antenatal maternal protein deprivation: sexually dimorphic programming of the pancreatic renin-angiotensin system. J Renin Angiotensin Aldosterone Syst. 2013;14:137–45.CrossRefPubMed Goyal R, Wong C, Van Wickle J, Longo LD. Antenatal maternal protein deprivation: sexually dimorphic programming of the pancreatic renin-angiotensin system. J Renin Angiotensin Aldosterone Syst. 2013;14:137–45.CrossRefPubMed
4.
go back to reference Goyal R, Goyal D, Leitzke A, Gheorghe CP, Longo LD. Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci. 2010;17:227–38.CrossRefPubMed Goyal R, Goyal D, Leitzke A, Gheorghe CP, Longo LD. Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci. 2010;17:227–38.CrossRefPubMed
5.
go back to reference Goyal R, Galffy A, Field SA, Gheorghe CP, Mittal A, Longo LD. Maternal protein deprivation: changes in systemic renin-angiotensin system of the mouse fetus. Reprod Sci. 2009;16:894–904.CrossRefPubMed Goyal R, Galffy A, Field SA, Gheorghe CP, Mittal A, Longo LD. Maternal protein deprivation: changes in systemic renin-angiotensin system of the mouse fetus. Reprod Sci. 2009;16:894–904.CrossRefPubMed
6.
go back to reference Goyal R, Longo LD. Maternal protein deprivation: sexually dimorphic programming of hypertension in the mouse. Hypertens Res. 2013;36:29–35.CrossRefPubMed Goyal R, Longo LD. Maternal protein deprivation: sexually dimorphic programming of hypertension in the mouse. Hypertens Res. 2013;36:29–35.CrossRefPubMed
7.
go back to reference Brawley L, Poston L, Hanson MA. Mechanisms underlying the programming of small artery dysfunction: review of the model using low protein diet in pregnancy in the rat. Arch Physiol Biochem. 2003;111:23–35 Brawley L, Poston L, Hanson MA. Mechanisms underlying the programming of small artery dysfunction: review of the model using low protein diet in pregnancy in the rat. Arch Physiol Biochem. 2003;111:23–35
8.
go back to reference Persson E, Jansson T. Low birth weight is associated with elevated adult blood pressure in the chronically catheterized guinea-pig. Acta Physiol Scand. 1992;145:195–6 Persson E, Jansson T. Low birth weight is associated with elevated adult blood pressure in the chronically catheterized guinea-pig. Acta Physiol Scand. 1992;145:195–6
9.
go back to reference Gilbert JS, Lang AL, Grant AR, Nijland MJ. Maternal nutrient restriction in sheep: hypertension and decreased nephron number in offspring at 9 months of age. J Physiol. 2005;565:137–47. Gilbert JS, Lang AL, Grant AR, Nijland MJ. Maternal nutrient restriction in sheep: hypertension and decreased nephron number in offspring at 9 months of age. J Physiol. 2005;565:137–47.
10.
go back to reference Sandberg K, Ji H. Sex differences in primary hypertension. Biol sex dif. 2012;3:7.CrossRef Sandberg K, Ji H. Sex differences in primary hypertension. Biol sex dif. 2012;3:7.CrossRef
11.
go back to reference Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med. 2002;5:27–37.PubMed Kannel WB. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med. 2002;5:27–37.PubMed
12.
go back to reference Burt VL et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305–13.CrossRefPubMed Burt VL et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305–13.CrossRefPubMed
13.
go back to reference Marks LS, Maxwell MH. Tigerstedt and the discovery of renin. An historical note. Hypertension. 1979;1:364–88.CrossRef Marks LS, Maxwell MH. Tigerstedt and the discovery of renin. An historical note. Hypertension. 1979;1:364–88.CrossRef
14.
go back to reference Goyal R, Leitzke A, Goyal D, Gheorghe CP, Longo LD. Antenatal maternal hypoxic stress: adaptations in fetal lung Renin-Angiotensin system. Reprod Sci. 2011;18:180–9.CrossRefPubMedCentralPubMed Goyal R, Leitzke A, Goyal D, Gheorghe CP, Longo LD. Antenatal maternal hypoxic stress: adaptations in fetal lung Renin-Angiotensin system. Reprod Sci. 2011;18:180–9.CrossRefPubMedCentralPubMed
15.
go back to reference Laragh JH, Mancia G. A symposium: systemic hypertension: contribution of trandolapril, a new angiotensin-converting enzyme inhibitor, toward patient protection. Introduction Am J Cardiol. 1992;70:1D–3.CrossRef Laragh JH, Mancia G. A symposium: systemic hypertension: contribution of trandolapril, a new angiotensin-converting enzyme inhibitor, toward patient protection. Introduction Am J Cardiol. 1992;70:1D–3.CrossRef
16.
go back to reference Messerli FH, Oparil S, Feng Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol. 2000;86:1182–7.CrossRefPubMed Messerli FH, Oparil S, Feng Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol. 2000;86:1182–7.CrossRefPubMed
17.
go back to reference Schnaper HW. Angiotensin-converting enzyme inhibitors for systemic hypertension in young and elderly patients. Am J Cardiol. 1992;69:54C–8.CrossRefPubMed Schnaper HW. Angiotensin-converting enzyme inhibitors for systemic hypertension in young and elderly patients. Am J Cardiol. 1992;69:54C–8.CrossRefPubMed
18.
go back to reference Forslund T, Tikkanen I, Gronhagen-Riska C, Fyhrquist F. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats. Acta Pharmacol Toxicol (Copenh). 1981;49:416–21.CrossRefPubMed Forslund T, Tikkanen I, Gronhagen-Riska C, Fyhrquist F. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats. Acta Pharmacol Toxicol (Copenh). 1981;49:416–21.CrossRefPubMed
19.
go back to reference Wallace KB, Bailie MD, Hook JB. Development of angiotensin-converting enzyme in fetal rat lungs. Am J Physiol. 1979;236:R57–60.PubMed Wallace KB, Bailie MD, Hook JB. Development of angiotensin-converting enzyme in fetal rat lungs. Am J Physiol. 1979;236:R57–60.PubMed
20.
go back to reference Bogdarina I, Welham S, King PJ, Burns SP, Clark AJL. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circulation Research. 2007;100:520–6.CrossRefPubMedCentralPubMed Bogdarina I, Welham S, King PJ, Burns SP, Clark AJL. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circulation Research. 2007;100:520–6.CrossRefPubMedCentralPubMed
21.
go back to reference Whitesall SE, Hoff JB, Vollmer AP, D’Alecy LG. Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol. 2004;286:H2408–15.CrossRefPubMed Whitesall SE, Hoff JB, Vollmer AP, D’Alecy LG. Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol. 2004;286:H2408–15.CrossRefPubMed
22.
go back to reference Starr A et al. A reactive oxygen species-mediated component in neurogenic vasodilatation. Cardiovasc Res. 2008;78:139–47.CrossRefPubMed Starr A et al. A reactive oxygen species-mediated component in neurogenic vasodilatation. Cardiovasc Res. 2008;78:139–47.CrossRefPubMed
23.
go back to reference Shue EH, Carson-Walter EB, Liu Y, Winans BN, Ali ZS, Chen J, et al. Plasmalemmal Vesicle Associated Protein-1 (PV-1) is a marker of blood–brain barrier disruption in rodent models. BMC Neurosci. 2008;9:29. Shue EH, Carson-Walter EB, Liu Y, Winans BN, Ali ZS, Chen J, et al. Plasmalemmal Vesicle Associated Protein-1 (PV-1) is a marker of blood–brain barrier disruption in rodent models. BMC Neurosci. 2008;9:29.
24.
go back to reference Huang BS, White RA, Ahmad M, Jeng AY, Leenen FH. Central infusion of aldosterone synthase inhibitor prevents sympathetic hyperactivity and hypertension by central Na + in Wistar rats. Am J Physiol Regul Integr Comp Physiol. 2008;295:R166–72.CrossRefPubMedCentralPubMed Huang BS, White RA, Ahmad M, Jeng AY, Leenen FH. Central infusion of aldosterone synthase inhibitor prevents sympathetic hyperactivity and hypertension by central Na + in Wistar rats. Am J Physiol Regul Integr Comp Physiol. 2008;295:R166–72.CrossRefPubMedCentralPubMed
25.
go back to reference Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of experimental hypertension in mice. Hypertension. 1996;28:1064–9.CrossRefPubMed Johns C, Gavras I, Handy DE, Salomao A, Gavras H. Models of experimental hypertension in mice. Hypertension. 1996;28:1064–9.CrossRefPubMed
26.
go back to reference Ramakers C, Ruijter JM, Deprez RHL, Moorman AFM. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett. 2003;339:62–6.CrossRefPubMed Ramakers C, Ruijter JM, Deprez RHL, Moorman AFM. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett. 2003;339:62–6.CrossRefPubMed
27.
go back to reference Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing. Molecular cell. 2007;27:91–105.CrossRefPubMedCentralPubMed Grimson A, Farh KK-H, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing. Molecular cell. 2007;27:91–105.CrossRefPubMedCentralPubMed
28.
go back to reference Van Abeelen AF et al. The fetal origins of hypertension: a systematic review and meta-analysis of the evidence from animal experiments of maternal undernutrition. J Hypertens. 2012;30:2255–67.CrossRefPubMed Van Abeelen AF et al. The fetal origins of hypertension: a systematic review and meta-analysis of the evidence from animal experiments of maternal undernutrition. J Hypertens. 2012;30:2255–67.CrossRefPubMed
29.
go back to reference Curhan GC et al. Birth weight and adult hypertension and obesity in women. Circulation. 1996;94:1310–5.CrossRefPubMed Curhan GC et al. Birth weight and adult hypertension and obesity in women. Circulation. 1996;94:1310–5.CrossRefPubMed
30.
go back to reference Tsukuda K et al. Influence of angiotensin II type 1 receptor-associated protein on prenatal development and adult hypertension after maternal dietary protein restriction during pregnancy. J Am Soc Hypertens. 2012;6:324–30.CrossRefPubMed Tsukuda K et al. Influence of angiotensin II type 1 receptor-associated protein on prenatal development and adult hypertension after maternal dietary protein restriction during pregnancy. J Am Soc Hypertens. 2012;6:324–30.CrossRefPubMed
31.
go back to reference Komatsu T et al. Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2). DNA Seq. 2002;13:217–20.PubMed Komatsu T et al. Molecular cloning, mRNA expression and chromosomal localization of mouse angiotensin-converting enzyme-related carboxypeptidase (mACE2). DNA Seq. 2002;13:217–20.PubMed
32.
go back to reference Crackower MA et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–8.CrossRefPubMed Crackower MA et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–8.CrossRefPubMed
33.
go back to reference Ingelfinger JR. Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens. 2009;18:79–84.CrossRefPubMed Ingelfinger JR. Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease. Curr Opin Nephrol Hypertens. 2009;18:79–84.CrossRefPubMed
34.
go back to reference Patel SK et al. Association of ACE2 Genetic Variants With Blood Pressure, Left Ventricular Mass, and Cardiac Function in Caucasians With Type 2 Diabetes. Am J Hypertens. 2011;25:216–22.CrossRefPubMed Patel SK et al. Association of ACE2 Genetic Variants With Blood Pressure, Left Ventricular Mass, and Cardiac Function in Caucasians With Type 2 Diabetes. Am J Hypertens. 2011;25:216–22.CrossRefPubMed
35.
go back to reference Dobyns WB et al. Inheritance of most X-linked traits is not dominant or recessive, just X-linked. Am J Med Genet. 2004;129A:136–43.CrossRefPubMed Dobyns WB et al. Inheritance of most X-linked traits is not dominant or recessive, just X-linked. Am J Med Genet. 2004;129A:136–43.CrossRefPubMed
36.
go back to reference Liu J et al. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17Œ ≤ −oestradiol-dependent and sex chromosome-independent. Biol sex dif. 2010;1:6.CrossRef Liu J et al. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17Œ ≤ −oestradiol-dependent and sex chromosome-independent. Biol sex dif. 2010;1:6.CrossRef
37.
go back to reference Gupte M et al. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol. 2012;32:1392–9.CrossRefPubMedCentralPubMed Gupte M et al. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol. 2012;32:1392–9.CrossRefPubMedCentralPubMed
38.
go back to reference Goyal R, Lister R, Leitzke A, Goyal D, Gheorghe CP, Longo LD. Antenatal maternal hypoxic stress: adaptations of the placental renin-angiotensin system in the mouse. Placenta. 2011;32:134–9.CrossRefPubMed Goyal R, Lister R, Leitzke A, Goyal D, Gheorghe CP, Longo LD. Antenatal maternal hypoxic stress: adaptations of the placental renin-angiotensin system in the mouse. Placenta. 2011;32:134–9.CrossRefPubMed
39.
go back to reference Wang G et al. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens. 2009;23:78–84.CrossRefPubMed Wang G et al. Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis. Am J Hypertens. 2009;23:78–84.CrossRefPubMed
Metadata
Title
Antenatal maternal low protein diet: ACE-2 in the mouse lung and sexually dimorphic programming of hypertension
Authors
Ravi Goyal
Jonathan Van-Wickle
Dipali Goyal
Lawrence D. Longo
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Physiology / Issue 1/2015
Electronic ISSN: 1472-6793
DOI
https://doi.org/10.1186/s12899-015-0016-6

Other articles of this Issue 1/2015

BMC Physiology 1/2015 Go to the issue